Bio

Bio


Dr. Taylor was born and raised in rural Kansas and Pennsylvania, the youngest of four children. He headed to the big city of Providence, RI to study Neuroscience, East Asian Studies and Entrepreneurship at Brown University. Following graduation, his short-lived career in finance took him to Los Angeles, London and Tokyo, before he decided medicine was how he could directly help others who needed it the most. He attended the University of Pennsylvania where he developed a passion for health disparities, social justice and community medicine in West Philadelphia. As a medical student, he founded the nationally-recognized Cut Hypertension Program (www.cuthypertension.org), a blood pressure screening, education and referral program partnered with African American barbershops. He completed residency and chief residency at UCSF prior to joining the Stanford faculty and Stanford-Intermountain Fellowship in Population Health, Delivery Science, and Primary Care.

Dr. Taylor is a family physician, researcher, implementer, activist and educator. He is excited about the potential for innovative care models, financing and technology to improve the health of underserved populations. He is also interested in HIV primary care, mentoring black men of color in medicine and medical education in community clinics. In addition to his primary care practice at Stanford Family Medicine, Dr. Taylor provides HIV, MAT and Hep C treatment at the Roots Community Health Center in East Oakland where he also leads the community health navigator program for complex care patients.

For fulfillment outside of medicine, he loves being a new dad, plays the violin, travels, spends time outdoors and enjoys cooking with friends and family.

For more information on The Cut Hypertension Program, please visit www.cuthypertension.org; IG - @cuthypertensionprogram; FB – The Cut Hypertension Program

Clinical Focus


  • Family Medicine

Academic Appointments


Administrative Appointments


  • Stanford-Intermountain Fellowship in Population Health, Delivery Science, and Primary Care, Division of Primary Care and Population Health (2019 - Present)
  • Primary Care Physician, Roots Community Health Center (2019 - Present)
  • Founder and Director, The Cut Hypertension Program (2010 - Present)

Professional Education


  • Board Certification: HIV Specialist, American Academy of HIV Medicine (2019)
  • Residency: UCSF Family Medicine Residency (2019) CA
  • Board Certification: Family Medicine, American Board of Family Medicine (2018)
  • Medical Education: Perelman School of Medicine University of Pennsylvania (2015) PA
  • BA, BS, MSc, Brown University, Neuroscience / Neuroengineering, East Asian Studies, Entrepreneurship (2008)

Service, Volunteer and Community Work


  • Faculty Mentor for the Primary Care Leadership Program, National Medical Foundation (6/1/2018)

    Provide mentoring for medical/NP/PA students interning with community health centers to build the pipeline of providers from diverse backgrounds committed to caring for underserved patients.

    Location

    Oakland, CA

Teaching

Graduate and Fellowship Programs


Publications

All Publications


  • Assessing Knowledge of HIV Vaccines and Biomedical Prevention Methods Among Transgender Women in the New York City Tri-State Area Assessing Knowledge of HIV Vaccines and Biomedical Prevention Methods Among Transgender Women in the New York City Tri-State Area Taylor, N. K. 2020

    View details for DOI 10.1089/trgh.2019.0049

  • Use of Isoniazid Preventive Therapy for Tuberculosis Prophylaxis Among People Living With HIV/AIDS: A Review of the Literature JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES Briggs, M. A., Emerson, C., Modi, S., Taylor, N., Date, A. 2015; 68: S297–S305

    Abstract

    Tuberculosis (TB) is the leading preventable cause of death in persons living with HIV (PLHIV), accounting for over a quarter of all HIV-associated deaths in 2012. Isoniazid preventive therapy (IPT) has the potential to decrease TB-related cases and deaths in PLHIV; however, implementation of this has been slow in many high HIV- and TB-burden settings.We performed an assessment of the evidence for the use of IPT in adults living with HIV based on a review of the literature published from 1995 to 2013. Eligible articles included data on mortality, morbidity, or retention in care related to the provision of IPT to adults with HIV in low- or middle-income countries. Cost-effectiveness information was also abstracted.We identified 41 articles involving over 45,000 PLHIV. While there was little evidence to demonstrate that IPT reduced mortality in PLHIV, there was substantial evidence that IPT reduced TB incidence. While these findings were consistent irrespective of CD4 or antiretroviral therapy status, studies frequently demonstrated a greater benefit among patients with a positive TB skin test (TST). Duration of effectiveness and benefits of prolonged therapy varied across settings.This analysis supports World Health Organization recommendations for the provision of IPT to PLHIV to reduce TB-associated morbidity and serves to highlight the need to strengthen IPT implementation. While there appears to be a greater benefit of IPT among PLHIV who are TST positive, IPT should be provided to all PLHIV without presumptive TB when TST is not available.

    View details for DOI 10.1097/QAI.0000000000000497

    View details for Web of Science ID 000354123500006

    View details for PubMedID 25768869

    View details for PubMedCentralID PMC6381831

  • Improving utilization of and retention in PMTCT services: Can behavioral economics help? BMC HEALTH SERVICES RESEARCH Taylor, N., Buttenheim, A. M. 2013; 13: 406

    Abstract

    The most recent strategic call to action of the World Health Organization sets the elimination of pediatric HIV as a goal. While recent efforts have focused on building infrastructure and ensuring access to high-quality treatment, we must now turn our focus to the behavior change needed to eliminate vertical transmission. We make the case for the application of concepts from the field of behavioral economics to prevention of mother-to-child transmission (PMTCT) programs to more effectively address demand-side issues of uptake and retention.We introduce five concepts from the field of behavioral economics and discuss their application to PMTCT programs: 1) Mentor mothers who come from similar circumstances as PMTCT patients can serve as social references who provide temporally salient modeling of utilization of services and adherence to treatment. 2) Economic incentives, like cell phone minutes or food vouchers, that reward adherence to PMTCT protocols leverage present bias, the observation that people are generally biased toward immediate versus future awards. 3) Default bias, our preference for the default option, is already being used in many countries in the form of opt-out testing, and could be expanded to all PMTCT programs. 4) We are hardwired to avoid loss more than to pursue an equivalent gain. PMTCT programs can take advantage of loss aversion through the use of commitment contracts that incentivize mothers to return to the clinic in order to avoid both reputational and financial loss.Eliminating vertical transmission of HIV is an ambitious goal. To close the remaining gap, innovations are needed to address demand for PMTCT services. Behavioral economics offers a set of tools that can be engineered into PMTCT programs to increase uptake and improve retention with minimal investment.

    View details for DOI 10.1186/1472-6963-13-406

    View details for Web of Science ID 000328116700003

    View details for PubMedID 24112440

    View details for PubMedCentralID PMC3852550

Latest information on COVID-19